Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease

Kidney International

Volumn 69, Issue 2, 2006, Pages 266-271

  Chade, A R ^a   Brosh, D ^a   Higano, S T ^a   Lennon, R J ^b   Lerman, L O ^a   Lerman, A ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chronic kidney disease; Coronary flow reserve; Hypertension

Indexed keywords

ADENOSINE; CORONARY VASODILATING AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CALCULATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CHRONIC DISEASE; CORONARY CIRCULATION; CORONARY DISEASE; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 33644636751     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000031     Document Type: Article

References (58)

1. Levey AS, Beto JA, Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32: 853-906.
2. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
3. Collins AJ, Li S, Gilbertson DT et al. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl 2003; 64: S24-S31.
4. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
5. US Renal Data System. USRDS 2003 Annual Data Report; Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases: Bethesda, MD, 2003.
6. Tonelli M, Moye L, Sacks FM et al. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. [Summary for patients in Ann Intern Med 2003 Jan 21;138(2):I28; PMID: 12529112]. Ann Int Med 2003; 138: 98-104.
7. Reis SE, Olson MB, Fried L et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 2002; 105: 2826-2829.
8. Henry RM, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402-1407.
9. Fried LF, Shlipak MG, Crump C et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41: 1364-1372.
10. McClellan WM, Langston RD, Presley R. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. J Am Soc Nephrol 2004; 15: 1912-1919.
11. Luft FC. Renal disease as a risk factor for cardiovascular disease. Basic Res Cardiol 2000; 95(Suppl 1): I72-I76.
12. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000; 356: 147-152.
13. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000; 35: S117-S131.
14. Garg AX, Clark WF, Haynes RB et al. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 2002; 61: 1486-1494.
15. Culleton BF, Larson MG, Wilson PW et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219.
16. Herrero P, Markham J, Bergmann SR. Quantitation of myocardial blood flow with H2 15O and positron emission tomography: assessment and error analysis of a mathematical approach. J Comput Assist Tomogr 1989; 13: 862-873.
17. Geltman EM, Henes CG, Senneff MJ et al. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries [see comment]. J Am Coll Cardiol 1990; 16: 586-595.
18. Navar L, Evan A, Rosivall L. Microcirculation of the Kidneys. In: The Physiology and Pharmacology of the Microcirculation. New York, 1983.
19. Pallone TL, Robertson CR, Jamison RL. Renal medullary microcirculation. Physiol Rev 1990; 70: 885-920.
20. Sax FL, Cannon III RO, Hanson C et al. Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? N Engl J Med 1987; 317: 1366-1370.
21. Lekakis JP, Papamichael CM, Vemmos CN et al. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol 1998; 31: 541-546.
22. Klein R, Sharrett AR, Klein BE et al. Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities Study. Arteriosder Thromb Vasc Biol 2000; 20: 1644-1650.
23. Wong TY, Klein R, Sharrett AR et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA 2002; 287: 1153-1159.
24. Imig JD, Inscho EW. Adaptations of the renal microcirculation to hypertension. Microcirculation 2002; 9: 315-328.
25. Burchfiel CM, Tracy RE, Chyou PH et al. Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol 1997; 17: 760-768.
26. Kaski JC. Myocardial ischaemia in the hypertensive patient - the role of coronary microcirculation abnormalities. Eur Heart J 1993; 14(Suppl J): 32-37.
27. Kozakova M, Palombo C, Pratali L et al. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29: 551-559.
28. Schwartzkopff B, Motz W, Frenzel H et al. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993-1003.
29. Best PJ, Lennon R, Ting HH et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119.
30. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315.
31. Shlipak MG, Fried LF, Crump C et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 2002; 62: 997-1004.
32. Perticone F, Maio R, Tripepi G et al. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004; 110: 821-825.
33. Coresh J, Wei GL, McQuillan G et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001; 161: 1207-1216.
34. Fesler P, Du Cailar G, Ribstein J et al. Left ventricular remodeling and renal function in never-treated essential hypertension. J Am Soc Nephrol 2003; 14: 881-887.
35. Heagerty AM, Aalkjaer C, Bund SJ et al. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 1993; 21: 391-397.
36. Rizzoni D, Porteri E, Castellano M et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28: 785-790.
37. Folkow B, Grimby G, Thulesius O. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand 1958; 44: 255-272.
38. Mulvany MJ. The fourth Sir George Pickering memorial lecture. The structure of the resistance vasculature in essential hypertension. J Hypertens 1987; 5: 129-136.
39. Rizzoni D, Palombo C, Porteri E et al. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 2003; 21: 625-631.
40. Rizzoni D, Porteri E, Boari GE et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108: 2230-2235.
41. Opherk D, Mall G, Zebe H et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69: 1-7.
42. Brush Jr JE, Cannon III RO, Schenke WH et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319: 1302-1307.
43. Mullins PA, Chauhan A, Sharples L et al. Impairment of coronary flow reserve in orthotopic cardiac transplant recipients with minor coronary occlusive disease. Br Heart J 1992; 68: 266-271.
44. Fehr T, Ammann P, Garzoni D et al. Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia. Kidney Int 2004; 66: 1206-1211.
45. Johnson RJ, Kang DH, Feig D et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190.
46. Harris NR, Rumbaut RE. Age-related responses of the microcirculation to ischemia-reperfusion and inflammation. Pathophysiology 2001; 8: 1-10.
47. Degens H. Age-related changes in the microcirculation of skeletal muscle. Adv Exp Med Biol 1998; 454: 343-348.
48. Damber JE, Bergh A, Widmark A. Age-related differences in testicular microcirculation. Int J Androl 1990; 13: 197-206.
49. Senneff MJ, Geltman EM, Bergmann SR. Noninvasive delineation of the effects of moderate aging on myocardial perfusion. J Nucl Med 1991; 32: 2037-2042.
50. Czernin J, Muller P, Chan S et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993; 88: 62-69.
51. Manjunath G, Tighiouart H, Coresh J et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63: 1121-1129.
52. Reis SE, Holubkov R, Conrad Smith AJ et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 2001; 141: 735-741.
53. Arant CB, Wessel TR, Olson MB et al. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cordiol 2004; 43: 2009-2014.
54. Pereira AA, Sarnak MJ. Anemia as a risk factor for cardiovascular disease. Kidney Int Suppl 2003; 64: S32-S39.
55. Hasdai D, Cannan CR, Mathew V et al. Evaluation of patients with minimally obstructive coronary artery disease and angina. Int J Cardiol 1996; 53: 203-208.
56. Al Suwaidi J, Reddan DN, Williams K et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974-980.
57. Klocke FJ. Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. Circulation 1987; 76: 1183-1189.
58. Hasdai D, Holmes Jr DR, Higano ST et al. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc 1998; 73: 1133-1140.